| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.03 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |